Physician profile
Ryan Taban
NPI 1235253196
$3,479.18
in general payments reported to CMS, 2019-2025
18 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $879 · 2020: $307 · 2021: $393 · 2022: $686 · 2023: $466 · 2024: $436 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,213.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $715.52 | 2019-2025 | Rocklatan, Tryptyr, Clareon |
| Aerie Pharmaceuticals, INC. | $477.47 | 2019-2021 | |
| Allergan, INC. | $413.43 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $294.39 | 2022-2024 | Vyzulta, Miebo, Prolensa |
| Sun Pharmaceutical Industries INC. | $259.27 | 2019-2022 | |
| Shire North American Group INC | $241.59 | 2019 | |
| Abbvie INC. | $236.86 | 2022-2025 | Xen Glaucoma Treatment System |
| Novartis Pharmaceuticals Corporation | $209.46 | 2019-2023 | |
| Oyster Point Pharma, INC. | $207.97 | 2022-2025 | Tyrvaya |
| Amgen INC. | $108.67 | 2024-2025 | Tepezza |
| Rxsight INC | $70.38 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Horizon Therapeutics Plc | $63.69 | 2023 | Tepezza |
| Thea Pharma INC. | $46.78 | 2022-2023 | |
| Akorn Operating Company LLC | $41.23 | 2021 | |
| Akorn, INC. | $29.98 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $29.75 | 2020 | |
| Topcon Healthcare Solutions, INC. | $16.90 | 2019 | |
| Glaukos Corporation | $15.84 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Taban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.